As reported by Le Journal des Entreprises,
“Spring 2024 saw Aix-based Softway Medical Group take a major step forward.” Softway Medical, a major player in e-health, has indeed moved up a level by completing the acquisition of the Belgian company SBIM.
The deal marks a turning point in the story of Softway Medical, representing its first foray into external growth outside France and kicking off ambitious European expansion plans.
A strategic partnership
SBIM, a renowned Belgian company with 70 employees, with software already used in 85% of hospitals in the Wallonia-Brussels region, with a turnover of €12 million, was a natural partner for Softway Medical.
This acquisition has therefore enabled Softway Medical to consolidate its presence in the Belgian market while broadening its horizons to other European countries.
Expansion beyond Belgium
Softway Medical’s expansion is not limited to Belgium. Indeed, the SBIM acquisition serves as a springboard to other European markets, notably Luxembourg, Flanders, the Netherlands and Germany.
A unique approach to growth
Unlike other European software publishers who favour acquisitions and offer country-specific products, Softway Medical is focusing on organic growth based on strong partnerships. This unique approach gives Softway Medical a significant competitive advantage, strengthening its position as a leader in the European digital healthcare market.
